Table 1 Expression of MRPL13 in different types of ovarian tissue.

From: MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6

Groups

Cases

Low

High

Positive rate (%)

High positive rate (%)

-

+

++

+++

Malignant

114

7

23

40

44

93.86a,b

73.68c,d

Borderline

33

10

10

12

1

69.70e,f

39.39g,h

Benign

31

18

7

6

0

41.94

19.35

Normal

13

9

2

2

0

30.77

15.38

  1. aMalignant vs. benign (***, P < 0.001).
  2. bMalignant vs. normal (***, P < 0.001).
  3. cMalignant vs. benign (***, P < 0.001).
  4. dMalignant vs. normal (***, P < 0.001).
  5. eBorderline vs. benign (*, P < 0.05).
  6. fBorderline vs. normal (*, P < 0.05).
  7. gBorderline vs. benign (P = 0.080).
  8. hBorderline vs. normal (P = 0.224).
Back to article page